IP Library Granted Patent US 8,916,585
Granted Patent B2
US 8,916,585 · App. 13/599,161 · Granted Dec 23, 2014

Nitrogen-containing heteroaryl compounds and methods of use thereof

Inventors: Michael P. Arend (San Mateo, CA); Lee A. Flippin (Woodside, CA); Volkmar Guenzler-Pukall (San Leandro, CA); Wen-Bin Ho (Los Altos, CA); Eric D. Turtle (Belmont, CA); Xiaohui Du (Foster City, CA)
Assignee: Fibrogen, Inc.
A61K38/1816C07D217/26A61K31/472C07D401/04C07D401/06C07D221/08C07D217/24C07D401/12C07D403/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,916,585
App. No.
13/599,161
Granted
Dec 23, 2014
Kind
B2
Abstract

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Claims (209)

1. A compound represented by formula

wherein:

q is zero or one;

W is selected from the group consisting of oxygen, —S(O) n — and —NR 9 — where n is zero, one or two, R 9 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, acyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic and R 8 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, or when W is —NR 9 — then R 8 and R 9 , together with the nitrogen atom to which they are bound, can be joined to form a heterocyclic or a substituted heterocyclic group, provided that when W is —S(O) n — and n is one or two, then R 8 is not hydrogen;

R 1 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, amino, substituted amino, aminoacyl, aryl, substituted aryl, halo, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, and —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl or, when X is —NR 7 —, then R 7 and R 6 , together with the nitrogen atom to which they are bound, can be joined to form a heterocyclic or substituted heterocyclic group;

R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halo, hydroxy, cyano, —S(O) n —N(R 6 )—R 6 where n is 0, 1, or 2, —NR 6 C(O)NR 6 R 6 , —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, each R 6 is independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic provided that when X is —SO— or —SO 2 —, then R 6 is not hydrogen, and R 7 is selected from the group consisting of hydrogen, alkyl, aryl, or R 2 , R 3 together with the carbon atoms pendent thereto, form an aryl substituted aryl, heteroaryl, or substituted heteroaryl;

R 4 and R 5 are independently selected from the group consisting of hydrogen, halo, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl and —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two. R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl or, when X is —NR 7 —, then R 7 and R 6 , together with the nitrogen atom to which they are bound, can be joined to form a heterocyclic or substituted heterocyclic group;

R″ is selected from the group consisting of hydrogen and alkyl or R″ together with R′ and the nitrogen pendent thereto can be joined to form a heterocyclic or substituted heterocyclic group;

R′″ is selected from the group consisting of hydroxy, alkoxy, substituted alkoxy, acyloxy, cycloalkoxy, substituted cycloalkoxy, aryloxy, substituted aryloxy, heteroaryloxy, substituted heteroaryloxy, aryl, —S(O) n —R 10 wherein R 10 is selected from the group consisting or alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl and n is zero, one or two;

or a pharmaceutically acceptable salt thereof;

with the proviso that when R″ is hydrogen, q is zero, W is oxygen, and R 8 is hydrogen, then at least one of the following occurs:

1) R 1 is fluoro, bromo, iodo, alkyl, substituted alkyl, alkoxy, aminoacyl, substituted alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, or —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl;

2) R 2 is substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, fluoro, bromo, iodo, cyano, or —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl, provided that:

a) when R 2 is substituted alkyl such a substituent does not include trifluoromethyl;

b) —XR 6 is not alkoxy; and

c) when —XR 6 is substituted alkoxy such a substituent does not include benzyl or benzyl substituted by a substituent selected from the group consisting of (C 1 -C 5 ) alkyl and (C 1 -C 5 ) alkoxy or does not include a fluoroalkoxy substituent of the formula:

—O—[CH 2 ] x —C f H (2f+1−g) F g

where x is zero or one; f is an integer of from 1 to 5; and g is an integer of from 1 to (2f+1);

3) R 3 is substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, bromo, iodo, or —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl, provided that:

a) when R 3 is substituted alkyl such a substituent does not include trifluoromethyl;

b) —XR 6 is not alkoxy; and

c) when —XR 6 is substituted alkoxy such a substituent does not include benzyl or benzyl substituted by a substituent selected from the group consisting of (C 1 -C 5 ) alkyl and (C 1 -C 5 ) alkoxy or does not include a fluoroalkoxy substituent of the formula:

—O—[CH ] x —C f H (2f+1−g) F g

where x is zero or one; f is an integer of from 1 to 5, and g is an integer of from 1 to (2f+1);

4) R 4 is iodo, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, or —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl provided that:

a) when R 4 is substituted alkyl such a substituent does not include trifluoromethyl;

b) —XR 6 is not alkoxy; and

c) when —XR 6 is substituted alkoxy such a substituent does not include a fluoroalkoxy substituent of the formula:

—O—[CH 2 ] x —C f H (2f+1−g) F g

where x is zero or one; f is an integer of from 1 to 5; and g is an integer of from 1 to (2f+1); or

5) R 5 is iodo, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, or —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl, provided that:

a) when R 5 is substituted alkyl such a substituent does not include trifluoromethyl;

b) —XR 6 is not alkoxy; and

c) when —XR 6 is substituted alkoxy such a substituent does not include a fluoroalkoxy substituent of the formula:

—O—[CH 2 ] x —C f H (2f+1−g) F g

where x is zero or one; f is an integer of from 1 to 5; and g is an integer of from 1 to (2f+1).

2. A compound as in claim 1 , wherein R 1 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, halo, alkoxy, aryloxy, substituted aryloxy, substituted aryl, alkylthio, aminoacyl, aryl, substituted amino, heteroaryl, heteroaryloxy, —S(O) n -aryl, —S(O) n -substituted aryl, —S(O) n -heteroaryl, and —S(O) n -substituted heteroaryl, where n is zero, one or two.

3. A compound as in claim 1 , wherein R 1 is selected from the group consisting of:

(4-methoxy)phenylsulfonylamino;

2,6-dimethylphenoxy;

3,4-difluorophenoxy;

3,5-difluorophenoxy;

3-chloro-4-fluorophenoxy;

3-methoxy-4-fluorophenoxy;

3-methoxy-5-fluorophenoxy;

4-(methylsulfonamido)phenoxy;

4-(phenylsulfonamido)phenoxy;

4-CF 3 —O-phenoxy;

4-CF 3 -phenoxy;

4-chlorophenoxy;

4-fluorophenoxy;

4-(4-fluorophenoxy)phenoxy;

4-methoxyphenoxy;

4-nitrophenoxy;

benzyloxy;

bromo;

butoxy,

CF 3 ;

chloro;

fluoro;

hydrogen;

iodo;

isopropoxy;

methyl;

phenoxy;

phenyl;

phenylsulfanyl;

phenylsulfinyl;

phenylsulfonyl;

phenylurea;

pyridin-1-ylsulfanyl;

pyridin-3-yloxy; and

pyridin-4-ylsulfanyl.

4. A compound as in claim 1 , wherein R 2 is selected from the group consisting of substituted amino, aryloxy, substituted aryloxy, alkoxy, substituted alkoxy, halo, hydrogen, alkyl, substituted alkyl, aryl, —S(O) n -aryl, —S(O) n -substituted aryl, —S(O) n -cycloalkyl, where n is zero, one or two, aminocarbonylamino, heteroaryloxy, and cycloalkyloxy.

5. A compound as in claim 4 , wherein R 2 is selected from the group consisting of:

(4-methoxy)phenylsulfonylamino;

2,6-dimethylphenoxy;

3,4-difluorophenoxy;

3,5-difluorophenoxy;

3-chloro-4-fluorophenoxy;

3-methoxy-4-fluorophenoxy;

3-methoxy-5-fluorophenoxy;

4-(methylsulfonamido)phenoxy;

4-(phenylsulfonamido)phenoxy;

4-CF 3 —O-phenoxy;

4-CF 3 -phenoxy;

4-chlorophenoxy;

4-fluorophenoxy;

4-(4-fluorophenoxy)phenoxy;

4-methoxyphenoxy;

4-nitrophenoxy;

benzyloxy;

bromo;

butoxy;

CF 3 ;

chloro;

cyclohexyloxy;

cyclohexylsulfanyl;

cyclohexylsulfonyl;

fluoro;

hydrogen;

iodo;

isopropoxy;

methyl;

phenoxy;

phenyl;

phenylsulfanyl;

phenylsulfinyl;

phenylsulfonyl;

phenylurea;

pyridin-1-ylsulfanyl;

pyridin-3-yloxy, and

pyridin-4-ylsulfanyl.

6. A compound as in claim 1 , wherein R 3 is selected from the group consisting of: substituted aryloxy, substituted alkoxy, alkoxy, substituted alkyl, alkyl, amino, cycloalkyloxy, hydrogen, halo, aryl, —S(O) n -aryl, —S(O) n ,-substituted aryl, —S(O) n -heteroaryl, —S(O) n -substituted heteroaryl, where n is zero, one or two, aminocarbonylamino, and heteroaryloxy.

7. A compound as in claim 6 , wherein R 3 is selected from the group consisting of:

amino;

(4-methyl)phenylsulfonylaminophenoxy;

3,4-difluorophenoxy;

3,5-difluorophenoxy;

3-fluoro-5-methoxy-phenoxy;

3-chloro-4-fluorophenoxy;

4-CF 3 —O-phenoxy;

4-CF 3 -phenoxy;

4-chlorophenoxy;

4-fluorophenoxy;

4-(4-fluorophenoxy)phenoxy;

4-methoxyphenoxy;

benzyloxy;

bromo;

butoxy;

CF 3 ;

chloro;

cyclohexyloxy,

hydrogen;

iodo;

isopropoxy;

phenoxy;

phenyl;

phenylsulfanyl;

phenyl sulfonyl;

phenylsulfinyl;

phenylurea;

pyridin-1-ylsulfanyl;

pyridin-3-yloxy; and

pyridin-4-ylsulfanyl.

8. A compound as in claim 1 , wherein R 2 and R 3 , combined with the carbon atoms pendent thereto, join to form an aryl group.

9. A compound as in claim 8 , wherein said aryl group is phenyl.

10. A compound as in claim 1 , wherein R 4 is selected from the group consisting of substituted arylthio, halo, hydrogen, substituted alkyl and aryl.

11. A compound as in claim 10 , wherein R 4 is selected from the group consisting of:

4-chlorophenyl sulfanyl;

chloro;

hydrogen;

methoxymethyl; and

phenyl.

12. A compound as in claim 1 , wherein R 5 is hydrogen or aryl.

13. A compound as in claim 12 , wherein R 5 phenyl.

14. A compound as in claim 1 , wherein R″ is hydrogen.

15. A compound as in claim 1 , wherein R′″ is selected from

the group consisting of hydrogen, hydroxy, alkoxy, substituted alkoxy, thiol, and acyloxy.

16. A compound as in claim 15 , wherein R′″ is selected from the group consisting of:

hydroxy;

benzyloxy;

ethoxy;

hydrogen;

thiol;

methoxy; and

methylcarbonyloxy.

17. A compound as in claim 1 , wherein WR 8 is selected from the group consisting of amino, substituted amino, hydroxy, and alkoxy.

18. A compound as in claim 17 , wherein WR 8 is selected from the group consisting of:

amino;

dimethylamino;

hydroxy;

methoxy; and

methylcarbonylamino.

19. A compound as in claim 1 , wherein said compound is represented by formula IIB:

wherein:

q is zero or one;

W is selected from the group consisting of oxygen, —S(O) n — and —NR 9 — where n is zero, one or two, R 9 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, acyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 8 is selected from the group consisting or hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic;

R″ is selected from hydrogen and alkyl;

R 1 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, halo, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, and —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl;

R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halo, hydroxy, cyano, and —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl;

R 4 and R 5 are independently selected from the group consisting of hydrogen, halo, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl and —XR 6 where X is oxygen, —S(O) n — or —NR 7 — where n is zero, one or two, R 6 is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic and substituted heterocyclic, and R 7 is hydrogen, alkyl or aryl; or

a pharmaceutically acceptable salt thereof.

20. A compound selected from the group consisting of:

1-Chloro-4-hydroxy-isoquinoline-3-carboxylic acid (2-amino-ethyl)-amide (trifluoro-acetic acid salt);

1-Chloro-4-hydroxy-isoquinoline-3-carboxylic acid (2-methoxy-ethyl)-amide;

1-Chloro-4-hydroxy-isoquinoline-3-carboxylic acid (2-hydroxy-ethyl)-amide;

1-Chloro-4-hydroxy-isoquinoline-3-carboxylic acid (2-dimethylamino-ethyl)-amide;

1-Chloro-4-hydroxy-isoquinoline-3-carboxylic acid (2-acetylamino-ethyl)-amide;

1-Chloro-4-hydroxy-6-isopropoxy-isoquinoline-3-carboxylic acid (2-methoxy-ethyl)-amide;

1-Chloro-4-hydroxy-6-isopropoxy-isoquinoline-3-carboxylic acid (2-amino-ethyl)-amide (trifluoro-acetic acid salt);

1-Chloro-4-hydroxy-6-isopropoxy-isoquinoline-3-carboxylic acid (2-dimethylamino-ethyl)-amide;

1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-amino-ethyl)-amide (trifluoro-acetic acid salt);

1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-methoxy-ethyl)-amide; and

1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-dimethylamino-ethyl)-amide;

or a pharmaceutically acceptable salt thereof.

21. A compound represented by the formula:

wherein:

R 2 and R 3 are independently selected from hydrogen or alkoxy;

W is selected from the group consisting of oxygen, and —NR 9 — where R 9 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, and acyl;

R 8 is selected from the group consisting of hydrogen, and alkyl;

or a pharmaceutically acceptable salt thereof;

with the proviso that when W is oxygen, then R 8 is not hydrogen.

22. A compound as in claim 21 , wherein R 2 is hydrogen or isopropoxy.

23. A compound as in claim 21 , wherein R 3 is hydrogen or isopropoxy.

24. A compound as in claim 21 , wherein WR 8 is selected from the group consisting of methoxy, amino, dimethylamino, and methylcarbonylamino.

25. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier or excipient.

26. A composition comprising the compound of claim 1 or a mixture of compounds of claim 1 in combination with at least one additional therapeutic agent.

27. The composition of claim 26 wherein the additional therapeutic agent is erythropoietin.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 3, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: FIBROGEN, INC.
Reel/Frame 072785/0760 →
SECURITY INTEREST Recorded May 1, 2023
From: FIBROGEN, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 063504/0221 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2013
From: AREND, MICHAEL P.; FLIPPIN, LEE A.; GUENZLER-PUKALL, VOLKMAR; HO, WEN-BIN; TURTLE, ERIC D.; DU, XIAOHUI
To: FIBROGEN, INC.
Reel/Frame 031215/0723 →
Continuity (8)
Continuation 13186351 · Jul 19, 2011
Continuation 12015275 · Jan 16, 2008
Division 10861082 · Jun 4, 2004
Provisional Application 60476519 · Jun 6, 2003
Provisional Application 60476633 · Jun 6, 2003
Provisional Application 60476420 · Jun 6, 2003
Provisional Application 60476811 · Jun 6, 2003
Related Publication 20130178417A1 · Jul 11, 2013